Albany, NY -- (SBWIRE) -- 04/07/2014 -- Hyaluronic acid also known as hyaluronan, hyaluronate or HA is a high molecular mass anionic polysaccharide present in fluid form in human body. Hyaluronic acid when to be used as medicine is extracted from rooster combs or produced from bacteria in laboratories. It is mostly used in treatment of knee osteoarthritis by injecting it into the patient’s knee joint and is also used for tissue healing post surgery. It acts as a lubricant in joints and other tissues and also helps in healing of injuries.
Hyaluronic acid products market is categorized on the basis of:
North America represents, both the largest and fastest-growing regional market for HA visco-supplementation due to increase in prevalence of obesity and growing aging population thus the resultant high prevalence of osteoarthritis. European countries and other emerging economies such as Brazil, Japan, India, China, Taiwan and South Korea are expected to show a significant growth in the global HA products market due to provision of cheaper treatment, improved reimbursement policies and increase in new product approvals.
Browse the full report with request TOC at http://www.transparencymarketresearch.com/hyaluronic-acid-products.html
Increase in the prevalence of disorders such as osteoarthritis and obesity is one of the major reasons driving the demand for hyaluronic acid products. Other factors responsible for fueling the hyaluronic acid products markets include exploring the use of hyaluronic acid in body joints other than knee such as shoulders and hips, increased patient compliance due to cost containment and shorter treatment regimens. Dicey reimbursement policies in developing areas of Europe and Asia and price competition amongst new market entrants may pose challenge to the hyaluronic acid products market.
Some of the key players in the hyaluronic acid products market include Anika Therapeutics, Inc., Bioniche Life Sciences, Inc., Bioventus LLC, Cadila Pharmaceuticals Ltd., DJO Global, Inc., Genzyme Corporation, Lupin Pharmaceuticals, Inc., Mylan, Inc., Sanofi S.A., Towa Pharmaceuticals Co., Ltd. and Uji Pharmaceutical Co., Ltd.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
90 State Street,
Albany NY - 12207
Browse More Market Reports:- http://sandyresearcher.wordpress.com/